More recently, HDAC inhibitors led to the correction of the NPC phenotype in cells with either one or two copies of the NPC1I1061T mutation, a correction mainly associated with increased expression of NPC1 protein [27]. Here, HDAC9 is linked to nasopharyngeal carcinoma.